-
ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway
Journal： Oncotarget
引用产品：anti-p-β-catenin antibdody()
ApplicationWB
IF0
SpeciesHuman
-
ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway
Journal： Oncotarget
引用产品：anti-c-Myc antibdody()
ApplicationWB
IF0
SpeciesHuman
-
ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway
Journal： Oncotarget
引用产品：anti-TCF4 antibdody(BS6172)
ApplicationWB
IF0
SpeciesHuman
-
ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway
Journal： Oncotarget
引用产品：anti-MMP-7 antibdody(BS6059)
ApplicationWB
IF0
SpeciesHuman
-
ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway
Journal： Oncotarget
引用产品：anti-β-actin antibdody(AP0060)
ApplicationWB
IF0
SpeciesHuman
-
ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway
Journal： Oncotarget
引用产品：anti-β-catenin antibdody()
ApplicationIF
IF0
SpeciesHuman
-
LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling
Journal： Oncotarget
引用产品：anti-c-Jun antibdody()
ApplicationIF,WB
IF0
SpeciesMouse,Human
-
LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling
Journal： Oncotarget
引用产品：anti-p-STAT3 antibdody()
ApplicationWB
IF0
SpeciesMouse,Human
-
LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling
Journal： Oncotarget
引用产品：anti-STAT3 antibdody()
ApplicationWB
IF0
SpeciesMouse,Human
-
LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling
Journal： Oncotarget
引用产品：anti-Lamin A antibdody(BS7013)
ApplicationWB
IF0
SpeciesMouse,Human
